78 results
8-K
EX-99.1
CCCC
C4 Therapeutics Inc
8 May 24
C4 Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights
7:07am
recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, drug undruggable targets and improve … bioavailable MonoDAC™ degrader designed to be highly potent and selective against its intended targets of Ikaros (IKZF1) and Aiolos (IKZF3) and overcome
ARS
2024 FY
CCCC
C4 Therapeutics Inc
30 Apr 24
Annual report to shareholders
8:52am
and optimize small molecule protein degraders that are highly active against their desired targets by harnessing the body’s natural process … , target currently “undruggable” targets and improve patient outcomes. To date, we have successfully designed and advanced several protein degraders
8-K
EX-99.1
hzcp8u5 bhc1ys
4 Mar 24
C4 Therapeutics Announces Strategic Discovery Research Collaboration with Merck KGaA, Darmstadt, Germany, Against Critical Oncogenic Proteins
7:05am
8-K
EX-99.1
jg39 kog52
22 Feb 24
C4 Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights
7:15am
8-K
EX-99.1
cuc7fjgco zu
11 Jan 24
Regulation FD Disclosure
7:05am
8-K
EX-99.1
jbin 2ugepfi
9 Jan 24
C4 Therapeutics Announces 2024 Priorities and Extended Cash Runway to Advance Portfolio of Targeted Protein Degradation Medicines
4:06pm
8-K
EX-99.2
yn8f2rpskpn 6ucz
12 Dec 23
Regulation FD Disclosure
4:28pm
8-K
EX-99.1
1j9l4pmd
12 Dec 23
Regulation FD Disclosure
4:28pm
8-K
EX-99.1
fwsru1v 1z
12 Dec 23
Entry into a Material Definitive Agreement
7:15am
8-K
advg2b07glgs56pr 6oe
12 Dec 23
Entry into a Material Definitive Agreement
7:15am
8-K
EX-99.1
0aeilod8njcsah
20 Nov 23
C4 Therapeutics Strengthens Board of Directors with Owen Hughes Appointment
7:05am
8-K
EX-99.1
l9z3ak64w
1 Nov 23
C4 Therapeutics Reports Third Quarter 2023 Financial Results and Recent Business Highlights
7:18am
8-K
EX-99.1
tb6nlk3hj 6wfd
5 Sep 23
C4 Therapeutics Announces Chief Financial Officer Succession
4:02pm